Close Menu

NEW YORK (GenomeWeb) – Molecular diagnostics firm OpGen has priced a private placement in which it hopes to raise $10.4 million.

The Gaithersburg, Maryland-based firm will issue 9,053,556 units at a price of $1.14375 each, consisting of one share of common stock and a warrant to purchase three quarters of one share. The five-year warrants will be exercisable 90 days after the placement closes, with an exercise price of $1.3125 per share.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.